A prospective registry study found a greater risk for infections associated with JAK inhibitors in adolescents and adults with moderate to severe atopic dermatitis compared with biologics.

A patch test for atopic dermatitis helps identify triggers and confirms diagnosis. Learn about self-testing and specialists ...

Atopic Dermatitis AD and Contact Dermatitis CD are skin conditions that lead to skin inflammation however their causes and ...

Underlying social and economic barriers in the U.S. may play a significant role in the higher rates of atopic dermatitis.

Janus kinase (JAK) inhibitors, including ruxolitinib cream and abrocitinib, demonstrate strong efficacy in atopic dermatitis ...

A large database study suggests that patients with primary dysautonomias face a significantly increased risk for seborrheic ...

Dupilumab treatment of atopic dermatitis resulted in long-term skin improvements linked to changes in skin’s the molecular composition.

Medically reviewed by Casey Gallagher, MD Atopic dermatitis (the most common type of eczema) causes dry, itchy skin with ...

Other experts believe that they’re two distinct conditions. Treatment for perioral dermatitis can vary depending on how severe it is and how often it reoccurs. The American Osteopathic College ...

PFIZER, a global biopharmaceutical company, today announced the availability of Cibinqo (abrocitinib) and Staquis (crisaborole) as new additions to the atopic dermatitis treatment spectrum in Malaysia ...

Combining Deep Pruritus Relief, Effective Skin Clearance, and a Well-tolerated Safety ProfileHONG KONG, Apr 9, 2025 - (ACN Newswire) - SinoMab BioScience ...